Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | AYTU BIOPHARMA INC | — | 792,289.0 | $2.2M | 0.87% | -21K | -2.6% | $2.73 | — |
| 22 | — | CURIS INC | — | 3,726,406.0 | $2.0M | 0.82% | +3.7M | +6178.8% | $0.55 | — |
| 23 | EOLS CALL | EVOLUS INC | Healthcare | 420,000.0 | $1.7M | 0.69% | NEW | — | $4.11 | +51.2% |
| 24 | XERS CALL | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 280,000.0 | $1.6M | 0.65% | NEW | — | $5.80 | +7.2% |
| 25 | TELA | TELA BIO INC | Healthcare | 2,617,252.0 | $1.6M | 0.65% | +265K | +11.3% | $0.62 | +32.3% |
| 26 | — | INHIBIKASE THERAPEUTICS INC | — | 957,202.0 | $1.6M | 0.64% | -1.4M | -59.2% | $1.68 | — |
| 27 | — | CRESCENT BIOPHARMA INC. | — | 85,000.0 | $1.6M | 0.62% | -3K | -3.1% | $18.37 | — |
| 28 | — | ADICET BIO INC | — | 221,955.0 | $1.5M | 0.60% | +2K | +0.9% | $6.81 | — |
| 29 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 335,309.0 | $1.4M | 0.56% | -258K | -43.5% | $4.13 | -2.8% |
| 30 | — | OKYO PHARMA LTD | — | 850,000.0 | $1.4M | 0.55% | NEW | — | $1.61 | — |
| 31 | SIBN CALL | SI BONE INC | Healthcare | 100,000.0 | $1.3M | 0.51% | NEW | — | $12.63 | +15.1% |
| 32 | MNKD CALL | MANNKIND CORP | Healthcare | 500,000.0 | $1.2M | 0.49% | NEW | — | $2.45 | +43.0% |
| 33 | HRTX | HERON THERAPEUTICS INC | Healthcare | 1,402,191.0 | $1.1M | 0.45% | +164K | +13.3% | $0.80 | +9.5% |
| 34 | LUNG | PULMONX CORP | Healthcare | 768,288.0 | $991K | 0.40% | +282K | +58.0% | $1.29 | +19.7% |
| 35 | INAB | IN8BIO INC | Healthcare | 663,412.0 | $982K | 0.39% | +499K | +302.3% | $1.48 | +13.5% |
| 36 | NMRA CALL | NEUMORA THERAPEUTICS INC. | Healthcare | 500,000.0 | $975K | 0.39% | NEW | — | $1.95 | -6.9% |
| 37 | — | SURROZEN INC | — | 33,005.0 | $961K | 0.39% | -81K | -71.0% | $29.13 | — |
| 38 | CTMX CALL | CYTOMX THERAPEUTICS INC. | Healthcare | 200,000.0 | $940K | 0.38% | NEW | — | $4.70 | -22.2% |
| 39 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 200,000.0 | $940K | 0.38% | NEW | — | $4.70 | -22.2% |
| 40 | DCTH CALL | DELCATH SYS INC | Healthcare | 100,000.0 | $928K | 0.37% | NEW | — | $9.28 | +16.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%